Feedback / Questions
Koselugo (selumetinib) - Merck (MSD), AstraZeneca
Koselugo: Newly added patent in Orange Book
(Orange Book)
-
Jul 7, 2025 -
Expiry on Mar 26, 2029
Patent
•
Genetic Disorders • Neurofibromatosis • Rare Diseases
https://www.accessdata.fda.gov/scripts/cder/ob/search_patent.cfm?listed=new
Jul 7, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious